Minoxidil Sexual Side Effects: What Evidence Shows
This is a research-based fact check, not medical advice. The findings summarized here come from peer-reviewed studies and are presented without added opinions. Consult a certified healthcare practitioner before making any treatment decision.
Verdict
The FDA label for topical minoxidil does not list sexual side effects. Between 2004 and 2014, the FDA adverse event reporting system received 8 reports of sexual side effects among minoxidil users across an entire decade of widespread use. One case report documents reversible erectile dysfunction linked to topical minoxidil 5%. No randomised controlled trial has studied whether minoxidil causes sexual dysfunction. The current evidence is insufficient to confirm causation. This contrasts sharply with finasteride, which has confirmed sexual side effects in clinical trials at rates of 1-2%.
Key takeaways
- The FDA label for topical minoxidil does not list sexual side effects.
- 8 reports of sexual side effects in 10 years of FDA adverse event data (2004-2014) across millions of users.
- No controlled clinical trial has studied whether topical minoxidil causes sexual dysfunction.
- One case report documents reversible erectile dysfunction with positive rechallenge on topical minoxidil 5%.
- Minoxidil does not block DHT, the hormonal mechanism that explains finasteride's confirmed sexual side effects does not apply.
- Finasteride carries confirmed sexual side effects at 1-2% in clinical trials. Minoxidil has no equivalent evidence.
What the evidence shows
Concerns about minoxidil and sexual side effects circulate widely online, but the clinical evidence base is extremely thin. Topical minoxidil is FDA-approved for hair loss and its drug label, which is required to list all adverse effects identified in clinical testing, does not include sexual side effects. For context on the full side effect profile of topical minoxidil, see our minoxidil side effects guide. For the broader range of hair loss treatment options, see the hair restoration guide.
The evidence that does exist comes from two sources: spontaneous adverse event reports submitted to the FDA, and a single published case report. Neither constitutes proof of causation.
FDA adverse event data
Researchers analysed the FDA Adverse Event Reporting System (FAERS) from 2004 to 2014 across all alopecia drug users. Across the entire 10-year period, 8 sexual side effect reports were received for minoxidil users: 4 cases of erectile dysfunction, 2 cases of decreased libido, and 2 other sexual effects. This is out of many millions of minoxidil users during that decade. The full FAERS analysis was published in 2017 and notes that spontaneous reporting has significant limitations, it cannot establish causation, and it is subject to underreporting and confounding.
The same analysis found that erectile dysfunction was reported in 4.35% of male minoxidil cases in the FAERS database, compared to 50.39% of finasteride cases. The difference was statistically significant, strongly suggesting that whatever sexual effects are associated with minoxidil, they are far less frequent and less severe than those associated with finasteride.
Case report evidence
One published case report documents a man who developed erectile dysfunction and decreased libido after 4 months of topical minoxidil 5% use. His symptoms improved after stopping the drug and returned when he restarted it. This rechallenge pattern is the strongest evidence of a causal link that exists, but a case report with a sample size of one cannot establish how commonly this occurs.
Comparison with finasteride
The comparison with finasteride is important for anyone weighing hair loss treatment options. Finasteride's sexual side effects are well-established in randomised controlled trials: in the pivotal 1-year Phase III trial, 1.4% of men experienced erectile dysfunction (versus 0.7% on placebo) and 1.2% discontinued because of sexual side effects. The mechanism is understood, finasteride blocks the conversion of testosterone to DHT, which has direct effects on sexual function.
Minoxidil works through a completely different mechanism as a vasodilator. It does not affect DHT, testosterone, or any sex hormone pathway. This is why, mechanistically, minoxidil is far less likely to cause sexual dysfunction than finasteride.
Minoxidil as a potential erectile dysfunction treatment
An angle that most sources miss entirely: a 2023 review in Sexual Medicine Reviews explored minoxidil as a potential treatment for erectile dysfunction, not a cause of it. As a vasodilator, minoxidil widens blood vessels, and the researchers proposed this mechanism could theoretically improve penile blood flow. The current StatPearls drug reference for minoxidil does not list sexual dysfunction as a recognised adverse effect. The clinical evidence for minoxidil treating ED is limited, but the vasodilatory mechanism suggests it is unlikely to cause the problem through the same pathway as finasteride.
Sexual side effects in women
The FAERS data and existing case reports focus on men. There is no published clinical evidence specifically addressing sexual side effects of topical minoxidil in women. Minoxidil is contraindicated during pregnancy and breastfeeding.
What to do if you experience sexual side effects
If you are using topical minoxidil and notice changes in sexual function, the appropriate first step is to speak with your prescribing doctor. It is worth noting whether the symptoms correlate in timing with starting or changing minoxidil, whether you are also using finasteride or any other medication, and whether other factors (stress, health changes, medications) could account for the symptoms. If you are using both minoxidil and finasteride, the evidence strongly suggests finasteride is the more likely cause of sexual side effects.
Evidence at a glance
| Source | Type | Key finding |
|---|---|---|
| Peng et al. 2017, FAERS analysis of minoxidil vs finasteride adverse events | Pharmacovigilance (adverse event data) | 8 sexual side effect reports for minoxidil over 10 years. ED reported in 4.35% of minoxidil FAERS cases vs 50.39% for finasteride. |
| Case report (published 2017), topical minoxidil 5% and sexual dysfunction | Single case report | ED and decreased libido resolved on stopping, returned on rechallenge. No other cases in the literature at time of publication. |
| StatPearls, Minoxidil drug reference (Patel et al. 2023) | Drug reference | Sexual side effects not listed in recognised adverse effects of topical minoxidil. |
What the research cannot tell you
- Whether topical minoxidil causes sexual dysfunction in a meaningful proportion of users. No controlled trial has studied this.
- The true rate of sexual side effects with minoxidil, if any. Spontaneous reporting significantly underestimates real-world rates and cannot establish causation.
- Whether the 8 FAERS reports represent true drug-caused effects or coincidental reports.
- Whether sexual side effects, if they occur, are reversible in all cases.
- Whether women experience sexual side effects from topical minoxidil.